Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1

Lade...
Vorschaubild
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
1996
Autor:innen
Loetscher, Marcel
Jones, Simon A.
Dahinden, Clemens A.
Arock, Michel
Moser, Bernhard
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
ArXiv-ID
Internationale Patentnummer
EU-Projektnummer
DFG-Projektnummer
Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
European Journal of Immunology. 1996, 26(4), pp. 753-758. ISSN 0014-2980. eISSN 1521-4141. Available under: doi: 10.1002/eji.1830260405
Zusammenfassung

The proteolytic cleavage product of complement component 3, (C3a), is like C4a and C5a, is a potent anaphylatoxin and induces the production of inflammatory mediators in phagocytes. Notably, mast cells respond to C3a with the release of vasoactive substances, including histamine. We have examined the function and receptor binding of C3a in a human leukemic mast cell line, HMC-1. Similar to chemoattractant agonists in leukocytes, C3a induced rapid cytosolic free calcium concentration increases in HMC-1 cells. EGTA did not diminish this response, indicating that mobilizable Ca2+ was from intracellular stores. Receptors of C3a in HMC-1 cells couple in part to Bordetella pertussis toxin-sensitive G-proteins and, therefore, appear to belong to the family of serpentine receptors that require G-proteins for signal transduction. HMC-1 cells express two types of C3a receptors, C3aR1 and C3aR2, that were shown to bind 125I-C3a with high-(Kd1 = 2.1-4.8 nM) or low-affinity (Kd2 = 30-150 nM), and both receptors are expressed at high level: 3 x 105-6 x 105 C3aR1/cell and 5 x 105-2.3 x 106 C3aR2/cell. Results from cross-linking experiments with 125I-C3a fully agree with the presence of two different classes of C3a receptors in HMC-1 cells. Two membrane proteins with apparent molecular masses of 54-61 kDa (p57) and 86-107 kDa (p97) could be covalently modified with 125I-C3a, and this cross-linking was inhibited with an excess of unlabeled C3a. Many of the known agonists for leukocytes including 13 chemokines (IL-8, NAP-2, GRO alpha, ENA-78, IP10, PF4, MCP-1, 2 and 3, RANTES, MIP-1 alpha, MIP-1 beta and I309), three neuropeptides (neuropeptide Y, somatostatin and calcitonin), as well as C5a, did not activate HMC-1 cells, indicating that C3a is one of a few protein ligands for which this cell line expresses specific receptors. The apparent selectivity for C3a and the abundant expression of C3a receptors make the HMC-1 cell line an excellent choice for the cloning of the receptor genes.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690LEGLER, Daniel F., Marcel LOETSCHER, Simon A. JONES, Clemens A. DAHINDEN, Michel AROCK, Bernhard MOSER, 1996. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. In: European Journal of Immunology. 1996, 26(4), pp. 753-758. ISSN 0014-2980. eISSN 1521-4141. Available under: doi: 10.1002/eji.1830260405
BibTex
@article{Legler1996-04Expre-37200,
  year={1996},
  doi={10.1002/eji.1830260405},
  title={Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1},
  number={4},
  volume={26},
  issn={0014-2980},
  journal={European Journal of Immunology},
  pages={753--758},
  author={Legler, Daniel F. and Loetscher, Marcel and Jones, Simon A. and Dahinden, Clemens A. and Arock, Michel and Moser, Bernhard}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/37200">
    <dc:contributor>Jones, Simon A.</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/37200"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-08T07:43:11Z</dc:date>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Loetscher, Marcel</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-08T07:43:11Z</dcterms:available>
    <dc:contributor>Arock, Michel</dc:contributor>
    <dc:contributor>Moser, Bernhard</dc:contributor>
    <dc:creator>Jones, Simon A.</dc:creator>
    <dc:creator>Legler, Daniel F.</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Moser, Bernhard</dc:creator>
    <dc:contributor>Legler, Daniel F.</dc:contributor>
    <dcterms:abstract xml:lang="eng">The proteolytic cleavage product of complement component 3, (C3a), is like C4a and C5a, is a potent anaphylatoxin and induces the production of inflammatory mediators in phagocytes. Notably, mast cells respond to C3a with the release of vasoactive substances, including histamine. We have examined the function and receptor binding of C3a in a human leukemic mast cell line, HMC-1. Similar to chemoattractant agonists in leukocytes, C3a induced rapid cytosolic free calcium concentration increases in HMC-1 cells. EGTA did not diminish this response, indicating that mobilizable Ca&lt;sup&gt;2+&lt;/sup&gt; was from intracellular stores. Receptors of C3a in HMC-1 cells couple in part to Bordetella pertussis toxin-sensitive G-proteins and, therefore, appear to belong to the family of serpentine receptors that require G-proteins for signal transduction. HMC-1 cells express two types of C3a receptors, C3aR1 and C3aR2, that were shown to bind &lt;sup&gt;125&lt;/sup&gt;I-C3a with high-(K&lt;sub&gt;d&lt;/sub&gt;1 = 2.1-4.8 nM) or low-affinity (K&lt;sub&gt;d&lt;/sub&gt;2 = 30-150 nM), and both receptors are expressed at high level: 3 x 10&lt;sup&gt;5&lt;/sup&gt;-6 x 10&lt;sup&gt;5&lt;/sup&gt; C3aR1/cell and 5 x 10&lt;sup&gt;5&lt;/sup&gt;-2.3 x 10&lt;sup&gt;6&lt;/sup&gt; C3aR2/cell. Results from cross-linking experiments with &lt;sup&gt;125&lt;/sup&gt;I-C3a fully agree with the presence of two different classes of C3a receptors in HMC-1 cells. Two membrane proteins with apparent molecular masses of 54-61 kDa (p57) and 86-107 kDa (p97) could be covalently modified with &lt;sup&gt;125&lt;/sup&gt;I-C3a, and this cross-linking was inhibited with an excess of unlabeled C3a. Many of the known agonists for leukocytes including 13 chemokines (IL-8, NAP-2, GRO alpha, ENA-78, IP10, PF4, MCP-1, 2 and 3, RANTES, MIP-1 alpha, MIP-1 beta and I309), three neuropeptides (neuropeptide Y, somatostatin and calcitonin), as well as C5a, did not activate HMC-1 cells, indicating that C3a is one of a few protein ligands for which this cell line expresses specific receptors. The apparent selectivity for C3a and the abundant expression of C3a receptors make the HMC-1 cell line an excellent choice for the cloning of the receptor genes.</dcterms:abstract>
    <dcterms:issued>1996-04</dcterms:issued>
    <dc:creator>Arock, Michel</dc:creator>
    <dc:contributor>Loetscher, Marcel</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:creator>Dahinden, Clemens A.</dc:creator>
    <dcterms:title>Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1</dcterms:title>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Dahinden, Clemens A.</dc:contributor>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet